{"mainPropery":{"diseaseId":6710,"diseaseName":"Hyperprolinemia type 2","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6710/hyperprolinemia-type-2","synonyms":["1 alpha pyrroline-5-carboxylate dehydrogenase deficiency","Type 2 hyperprolinemia","Hyperprolinemia type 2"],"synonyms-with-source":[{"name":"1 alpha pyrroline-5-carboxylate dehydrogenase deficiency"},{"name":"Type 2 hyperprolinemia"},{"name":"Hyperprolinemia type 2"}],"identifiers":[{"identifierType":"OMIM","identifierId":"239510"},{"identifierType":"ORPHANET","identifierId":"79101"},{"identifierType":"UMLS","identifierId":"C2931835"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"},{"diseaseTypeId":37,"diseaseTypeName":"Newborn Screening"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":917,"resourceName":"American Dietetic Association","address1":"120 South Riverside Plaza, Suite 2000","address2":"","address3":"","address4":"","city":"Chicago","state":"IL","zip":"60606-6995","country":"United States","phone":"","tollFree":"800-366-1655","fax":"","email":"knowledge@eatright.org","url":"http://www.eatright.org/Public/"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/239510' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=239510' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Hyperprolinemia type 2. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='https://medlineplus.gov/genetics/condition/hyperprolinemia/' target='_blank'>MedlinePlus Genetics</a> contains information on Hyperprolinemia type 2. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":824,"resourceId":1549,"resourceName":"Hyperprolinemia type 2","descriptionText":"The <a href='http://newbornscreeningcodes.nlm.nih.gov/nb/sc/condition/PRO-II ' target='_blank'>Newborn Screening Coding and Terminology Guide</a> has information on the standard codes used for  newborn screening tests. Using these standards helps compare data across different laboratories. This resource was created by the National Library of Medicine.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/580/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79101' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1539,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ResearchTrials_Search.php?lng=EN&type_list=researchtrials_search_simple_shd&data_id=11143&Disease(s)%20concerned=Hyperprolinaemia-type-II--Hyperprolinemia-type-II-&search=ResearchTrials_Search_Simple&ChdId=11143&ResearchTrials_ResearchTrials_Search_diseaseGroup=hyperprolinemia&ResearchTrials_ResearchTrials_Search_diseaseType=Pat&ResearchTrials_ResearchTrials_Search_country=NN&ResearchTrials_ResearchTrials_Search_GeographicType=null' target='_blank'>Orphanet</a> lists European clinical trials, research studies, and patient registries enrolling people with this condition.&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1541,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search.php?lng=EN&type_list=clinicalLabs_search_simple_shd&data_id=11143&Disease(s)%20concerned=Hyperprolinaemia-type-II--Hyperprolinemia-type-II-&search=ClinicalLabs_Search_Simple&ChdId=11143&ClinicalLabs_ClinicalLabs_Search_diseaseGroup=hyperprolinemia&ClinicalLabs_ClinicalLabs_Search_diseaseType=Pat&ClinicalLabs_ClinicalLabs_Search_country=NN&ClinicalLabs_ClinicalLabs_Search_GeographicType=null&ClinicalLabs_ClinicalLabs_Search_ClinicalLabsList_Sort=QoS' target='_blank'>Orphanet</a> lists international laboratories offering diagnostic testing for this condition.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:239510' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":1233,"questionText":"What is hyperprolinemia type 2?","answerText":"<strong>Hyperprolinemia type 2</strong>&nbsp;results in&nbsp;an excess of a particular protein building block (amino acid), called proline, in the blood. This condition generally occurs when proline is not broken down properly by the body.&nbsp;Hyperprolinemia type&nbsp;2&nbsp;causes proline levels in the blood to be 10 to 15 times higher than normal, and it also causes high levels of a related compound called pyrroline-5-carboxylate. Some people with this condition develop mild intellectual disability&nbsp;and <a href=\"http://www.nlm.nih.gov/medlineplus/seizures.html\" target=\"_blank\">seizures</a>; however, the symptoms of this disorder&nbsp;vary in severity among affected individuals.[741]","dateModified":"2013-11-01T10:38:00"},"basicQuestions":[{"questionId":1235,"questionText":"How might hyperprolinemia type 2 be treated?","answerText":"There is no specific treatment for hyperprolinemia type 2, even for those individuals who experience seizures. In general, if people with hyperprolinemia type 2 have symptoms, they are usually mild&nbsp;and do not require treatment.&nbsp;If seizures are present during childhood,&nbsp;they&nbsp;tend to&nbsp;disappear in adulthood. Attempts to reduce the amount of proline in an affected&nbsp;person's diet have resulted in only modest control of proline levels in the blood and have not reduced symptoms.[743]","dateModified":"2013-11-01T10:40:00","resourceClassificationName":"Treatment","references":[{"referenceId":743,"authors":"Phang JM, Hu CA, Valle D","articleTitle":"Disorders of proline and hydroxyproline metabolism","bookWebsiteJournalTitle":"The Metabolic and Molecular Bases of Inherited Disease","date":"2001","volume":"2","pages":"1821-1838","authors2":"Scriver CR, Beaudet AL, Sly WS, Valle D","placeOfPublication":"New York","publisher":"McGraw-Hill"}]},{"questionId":1234,"questionText":"Do individuals with hyperprolinemia type 2 have a shortened lifespan?","answerText":"After an extensive search of the information resources available to us, we were not able to locate any information to suggest that people with hyperprolinemia type 2 have a shortened lifespan. One study of hyperprolinemia type 2 in Ireland found that most adults had normal health[742]&nbsp;&nbsp;Children Living with Inherited Metabolic Diseases (CLIMB), an advocacy organization for&nbsp;individuals with metabolic disorders, also notes that when patients reach adulthood, they typically&nbsp;appear to be symptom-free.&nbsp;<br>","dateModified":"2013-10-17T17:09:00","resourceClassificationName":"Prognosis","references":[{"referenceId":742,"authors":"Flynn MP, Martin MC, Moore PT, Stafford JA, Fleming GA, Phang JM","articleTitle":"","bookWebsiteJournalTitle":"Archives of Disease in Childhood","date":"December 1989","volume":"64(12)","pages":"1699-1707","url":"http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=2624476","dateAccessed":"2008-11-03T00:00:00"}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":14540,"phenoTypeName":"Hydroxyprolinuria","percentRanges":"-"},{"phenoTypeId":14556,"phenoTypeName":"Hyperglycinuria","percentRanges":"-"},{"phenoTypeId":15621,"phenoTypeName":"Hyperprolinemia","percentRanges":"-"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","percentRanges":"-"},{"phenoTypeId":14578,"phenoTypeName":"Prolinuria","percentRanges":"-"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Hyperprolinemia_type_2"}